- Home
- JRS vs QTRX Comparison
JRS vs QTRX Comparison
Compare JRS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRS
- QTRX
- Stock Information
- Founded
- JRS 2001
- QTRX 2007
- Country
- JRS United States
- QTRX United States
- Employees
- JRS N/A
- QTRX N/A
- Industry
- JRS Finance/Investors Services
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- JRS Finance
- QTRX Industrials
- Exchange
- JRS Nasdaq
- QTRX Nasdaq
- Market Cap
- JRS 224.5M
- QTRX 261.7M
- IPO Year
- JRS N/A
- QTRX 2017
- Fundamental
- Price
- JRS $8.37
- QTRX $4.81
- Analyst Decision
- JRS
- QTRX Hold
- Analyst Count
- JRS 0
- QTRX 4
- Target Price
- JRS N/A
- QTRX $11.75
- AVG Volume (30 Days)
- JRS 86.6K
- QTRX 687.8K
- Earning Date
- JRS 01-01-0001
- QTRX 11-11-2025
- Dividend Yield
- JRS 8.87%
- QTRX N/A
- EPS Growth
- JRS N/A
- QTRX N/A
- EPS
- JRS N/A
- QTRX N/A
- Revenue
- JRS N/A
- QTRX $125,784,000.00
- Revenue This Year
- JRS N/A
- QTRX $2.23
- Revenue Next Year
- JRS N/A
- QTRX $36.01
- P/E Ratio
- JRS N/A
- QTRX N/A
- Revenue Growth
- JRS N/A
- QTRX N/A
- 52 Week Low
- JRS $5.95
- QTRX $4.05
- 52 Week High
- JRS $8.00
- QTRX $15.86
- Technical
- Relative Strength Index (RSI)
- JRS 75.10
- QTRX 50.31
- Support Level
- JRS $7.96
- QTRX $4.25
- Resistance Level
- JRS $8.21
- QTRX $4.60
- Average True Range (ATR)
- JRS 0.08
- QTRX 0.22
- MACD
- JRS 0.03
- QTRX 0.06
- Stochastic Oscillator
- JRS 96.51
- QTRX 84.21
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.